Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://emilyhdrb749909.mdkblog.com/45048744/trelaglutide-exploring-a-new-therapy-for-chronic-diseases